| Cecillia Tsao, MD | |
|
128 M St Nw, Washington, DC 20001-1205 | |
| (202) 854-3840 | |
| (202) 854-3854 |
| Full Name | Cecillia Tsao |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 128 M St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821101767 | NPI | - | NPPES |
| 035300800 | Medicaid | DC | |
| P00431121 | Other | DC | MEDICARE RAILROAD |
| 410695400 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MD034412 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health Services Inc | 4385541622 | 21 |
News Archive
New details from the Obama administration clear a way for the government to continue to pay for the bulk of the costs associated with providing health coverage to Capitol Hill staffers, though they must buy coverage on Obamacare exchanges instead of getting it through the Federal Employee Health Benefits Program. The rules say each congressional office should make the determination, however, about which employees move to exchanges and which can stay on the federal plans.
One of the most significant ways in which the human brain is unique is the size and structure of the cerebral cortex. But what drives the growth of the human cortex, likely the foundation for our unique intellectual abilities?
According to Australian scientists we are what our parents ate - scientists at the Baker IDI Heart and Diabetes Institute say that very specific molecular events occur after the consumption of food high in glucose, causing chemical changes to our genetic controls.
Researchers from the University of Exeter, Peninsula College of Medicine and Dentistry (PCMD), are working with clinicians from the South Western Ambulance Service NHS Foundation Trust (SWASFT) and the Royal Devon & Exeter Hospital NHS Foundation Trust (RD&E) to reduce the time it takes from the start of a stroke to the administration of vital clot-busting drug treatment.
Idera Pharmaceuticals, Inc. announced results of a Phase 1 clinical trial of IMO-8400, a first-in-class antagonist of Toll-like Receptors 7, 8, and 9 being developed for potential applications in autoimmune and inflammatory diseases.
› Verified 6 days ago
| Entity Name | Providence Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669453809 PECOS PAC ID: 4385541622 Enrollment ID: O20031216000187 |
News Archive
New details from the Obama administration clear a way for the government to continue to pay for the bulk of the costs associated with providing health coverage to Capitol Hill staffers, though they must buy coverage on Obamacare exchanges instead of getting it through the Federal Employee Health Benefits Program. The rules say each congressional office should make the determination, however, about which employees move to exchanges and which can stay on the federal plans.
One of the most significant ways in which the human brain is unique is the size and structure of the cerebral cortex. But what drives the growth of the human cortex, likely the foundation for our unique intellectual abilities?
According to Australian scientists we are what our parents ate - scientists at the Baker IDI Heart and Diabetes Institute say that very specific molecular events occur after the consumption of food high in glucose, causing chemical changes to our genetic controls.
Researchers from the University of Exeter, Peninsula College of Medicine and Dentistry (PCMD), are working with clinicians from the South Western Ambulance Service NHS Foundation Trust (SWASFT) and the Royal Devon & Exeter Hospital NHS Foundation Trust (RD&E) to reduce the time it takes from the start of a stroke to the administration of vital clot-busting drug treatment.
Idera Pharmaceuticals, Inc. announced results of a Phase 1 clinical trial of IMO-8400, a first-in-class antagonist of Toll-like Receptors 7, 8, and 9 being developed for potential applications in autoimmune and inflammatory diseases.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cecillia Tsao, MD 1150 Varnum St Ne, Washington, DC 20017-2180 Ph: (202) 854-4069 | Cecillia Tsao, MD 128 M St Nw, Washington, DC 20001-1205 Ph: (202) 854-3840 |
News Archive
New details from the Obama administration clear a way for the government to continue to pay for the bulk of the costs associated with providing health coverage to Capitol Hill staffers, though they must buy coverage on Obamacare exchanges instead of getting it through the Federal Employee Health Benefits Program. The rules say each congressional office should make the determination, however, about which employees move to exchanges and which can stay on the federal plans.
One of the most significant ways in which the human brain is unique is the size and structure of the cerebral cortex. But what drives the growth of the human cortex, likely the foundation for our unique intellectual abilities?
According to Australian scientists we are what our parents ate - scientists at the Baker IDI Heart and Diabetes Institute say that very specific molecular events occur after the consumption of food high in glucose, causing chemical changes to our genetic controls.
Researchers from the University of Exeter, Peninsula College of Medicine and Dentistry (PCMD), are working with clinicians from the South Western Ambulance Service NHS Foundation Trust (SWASFT) and the Royal Devon & Exeter Hospital NHS Foundation Trust (RD&E) to reduce the time it takes from the start of a stroke to the administration of vital clot-busting drug treatment.
Idera Pharmaceuticals, Inc. announced results of a Phase 1 clinical trial of IMO-8400, a first-in-class antagonist of Toll-like Receptors 7, 8, and 9 being developed for potential applications in autoimmune and inflammatory diseases.
› Verified 6 days ago
Dr. Adefolaju Oketokun, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |